wildlifeprotection.info Lifestyle Mims Drug Index Pdf

MIMS DRUG INDEX PDF

Friday, April 26, 2019


numerous times for their favorite novels like this mims drug guide, but end up in malicious MIMS, or the Monthly Index of Medical Specialities, has been providing Fahrenheit multiple choice test questions, la isla bonita tab, Ebook. PDF(doxylamine + pyridoxine): Learn about PDF's Dosage, Side Effects and indications. Now, GPs and nurses, and soon also practice pharmacists, can access the whole MIMS website, including the drug database, quick-reference tables, guideline.


Mims Drug Index Pdf

Author:GERARD SIMPKINS
Language:English, Spanish, Dutch
Country:Italy
Genre:Science & Research
Pages:157
Published (Last):31.05.2016
ISBN:487-4-35010-423-9
ePub File Size:18.55 MB
PDF File Size:20.82 MB
Distribution:Free* [*Regsitration Required]
Downloads:26283
Uploaded by: VICKIE

guide consumer guide Mims Drug Guide ePub comparison information and reviews of equipment you can use with MIMS User Manual - Manitoba. For over The CDSCO and NFI did not contain information about indication for 10 and 17 drugs, respectively, while MIMS and PI contained information about all the. If you ally craving such a referred mims drug guide ebook that will manage to pay for you All the MIMS medicine information delivered to you via the internet.

These drugs were chosen on the basis of prescription pattern in the hospital.

Two senior residents D. Clinical Pharmacology students and one PhD student collected and analyzed the PIs of the selected drugs. The following parameters were assessed.

The number of drugs out of the selected 50, whose indication information was missing in different sources.

Total number of indications given in different sources, in respect of these 50 drugs. Average number of indications per drug mentioned in different sources. After doing the above assessments, we did a subset analysis in respect of: Only those drugs whose indications were given in CDSCO website list. In the next step, we compared only those drugs whose indications were mentioned in all the four sources.

We also looked upon gross qualitative differences existing across various sources of drug information used in this study.

To find the difference between different sources, data were statistically analyzed by applying Friedman Test using Graph Pad Instat trial version software. Only MIMS contained information about all the 50 drugs.

The number of indications per drug was variable in all these four sources. The details of this information are given in Table 1.

NFI was excluded from this analysis as this source had information of only about 24 of these 40 drugs. In respect of these 40 drugs, the PI had listed maximum number of indications 2. Table 2 Open in a separate window To include NFI as well, a subset analysis was done in respect of those 24 drugs information about which were available in all the four sources including NFI. We found that NFI had listed maximum number of indications 3.

Table 3 Open in a separate window Qualitative differences After the quantitative comparison, we identified any gross qualitative mismatch in information across these four sources. Following gross discrepancies are observed: Of the 40 drugs mentioned in CDSCO, only broad single indication is mentioned in respect of some drugs e.

It is apparent that such abridged information only reflects the broad use of the drug without providing more specific and relevant information to the prescribing physicians.

MIMS overview

Labetalol is one of the preferred drugs for treatment of pregnancy induced hypertension, and its oral administration is considered as safe and effective as methyldopa. However, the indication information about some commonly used drugs such as prazosin, levofloxacin, and chlorthalidone was also missing in NFI. MIMS is a commercially available drug information compendium and was found to contain more number of indications as compared to the regulatory benchmark.

Since this source is commonly utilized for seeking drug information, such a discrepancy may encourage off-label, and sometimes irrational, use of drugs. PIs were also found to contain maximum indications over and above the ones mentioned in regulator's website. In our country, PIs are to be provided to the regulator at the time of registration. However, providing and publishing PIs along with drug packages in neither regulated nor mandatory.

However, when available, listing any indication in PI which is not in consonance with the regulator's website may again lead to off-label and possible irrational drug use.

On the basis of aforementioned, it can be safely inferred that the CDSCO website does not contain information about some commonly used drugs even while these drugs are marketed in India. These 10 drugs are part of 50 commonly prescribed drugs as identified for this study.

If all the drugs marketed in India are checked, this number may increase. Such a deficiency has the portent to compromise the robustness of regulatory benchmark and may lead to confusion regarding the appropriate use of drugs.

This study highlights the discrepancies in drug information available in various sources by taking a representative sample of commonly used drugs.

To the best of our knowledge, this study, though parsimonious in design, is the first such attempt to address this issue. These 50 drugs were identified on the basis of the prescription pattern in our hospital which is a tertiary care center.

One limitation of this study, is that, this prescription pattern may vary from one hospital to other, and a more broad based selection criteria for identifying drugs may be desirable. Variation exists in the quantity and quality of information on indications about drugs available in various sources. However, this information does not conform to regulatory benchmark all the time. CDSCO website is the regulatory benchmark and requires updating so as to provide a sound and reliable reference regarding drug information for all the stakeholders.

Further studies involving large sample of drugs and more variables such as side effect profile, dosage information, information on drug interactions, and special precautions and contraindications are required to further elucidate the issue of variation in drug information.

PHARMACOLOGY - Database of Medicines

National Center for Biotechnology Information , U. J Nat Sci Biol Med. Author information Copyright and License information Disclaimer. Address for correspondence: Abstract Background: Materials and Methods: Drug information, irrational drug use, off-label. Total number of indications given in different sources, in respect of these 50 drugs. Average number of indications per drug mentioned in different sources.

After doing the above assessments, we did a subset analysis in respect of: Table 1 Indication information about the selected drugs. Open in a separate window.

Table 3 Indication information available in all four sources.

Qualitative differences After the quantitative comparison, we identified any gross qualitative mismatch in information across these four sources. Following gross discrepancies are observed: Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest. Drug Benefits and Risks.

INTRODUCTION

Available from: Influence of physician's education, drug information and medical-care settings on the quality of drugs prescribed. Eur J Clin Pharmacol.

Drug information sources: Reported preferences by general practitioners. An online version is available, with all content save drug listings available for free.

MIMS overview

Concise drug monographs form the core of MIMS ; these include safety information, details of the active ingredient, presentation, price, indication, dosage and manufacturer. In addition, the book includes drug comparison tables, and summaries of clinical guidance. Drugs that are blacklisted i. Haymarket Group also publishes three related trade magazines: Several one-day clinical conferences are held each year on topics such as dermatology , women's health , diabetes , and respiratory disease.

MIMS Learning is an educational website for general practitioners and nurses offering clinical education modules.

The website has an integrated magazine, also named MIMS Learning , showcasing content from the website. From Wikipedia, the free encyclopedia.However, this information does not conform to regulatory benchmark all the time. In summary, prescribing of new drugs is not simply related to biomedical evaluation and critical appraisal but, more importantly, to the mode of exposure to pharmacological information and social influences on decision making.

January Past research has focused on medication advice over the telephone targeting the public or healthcare professionals, provided by clinical pharmacologists, clinical pharmacists, poison specialists and clinical anaesthetists [ 10 — 16 ]. MIMS toolbar button.

JEREMY from Los Angeles
See my other articles. I absolutely love valencian frontó. I am fond of studying docunments enormously .